← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Coridea, Llc
New York, NY
$18,694,541
Total funding
14
Grants
Funding over time
peak $3.7M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,694,541 · 14
By mechanism
R44$13,844,911 · 7
UH3$2,694,009 · 1
R43$1,228,302 · 5
UG3$927,319 · 1
Investigators at Coridea, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$2,544,126
UH3 · FY2025 · DA
Painless Defibrillation$994,306
R44 · FY2018 · HL
Painless Defibrillation$993,536
R44 · FY2019 · HL
Endobronchial Supervalve for the Treatment of Emphysema$988,194
R44 · FY2022 · HL
Painless Defibrillation$982,600
R44 · FY2020 · HL
ENT-based Approach to Cervical Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea$982,086
R44 · FY2025 · HL
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$941,991
R44 · FY2024 · HL
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose$927,319
UG3 · FY2023 · DA
Endobronchial Supervalve for the Treatment of Emphysema$805,212
R44 · FY2021 · HL
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy$784,548
R44 · FY2023 · HL
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation$784,016
R44 · FY2022 · CA
Novel Minimally Invasive Endobronchial Approach for Lung Cancer Ablation$783,896
R44 · FY2021 · CA
Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia$755,923
R44 · FY2018 · HL
Minimally Invasive Cardiac Sympathetic Denervation for Malignant Ventricular Arrhythmia$742,382
R44 · FY2019 · HL
Prevention of Syncope with GSN Stimulation$740,435
R44 · FY2016 · HL
Prevention of Syncope with GSN Stimulation$726,029
R44 · FY2017 · HL
Painless Defibrillation$505,020
R44 · FY2015 · HL
Painless Defibrillation$492,501
R44 · FY2016 · HL
Stellate Ganglion Stimulation in Septic Shock to Improve Hemodynamics and Vasopressor Requirements$274,839
R43 · FY2024 · GM
Endobronchial Supervalve for the Treatment of Emphysema$246,415
R44 · FY2020 · HL